Physician profile
Agnes Augustine
NPI 1285100487
$1,374.49
in general payments reported to CMS, 2019-2025
13 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $317 · 2022: $236 · 2023: $535 · 2024: $173 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800 · Education: $22.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.20 |
| Education | $22.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $506.88 | 2021-2024 | Gattex, Entyvio, Eohilia |
| Abbvie INC. | $416.87 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $137.99 | 2022-2025 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.96 | 2021-2024 | Xifaxan |
| Ironwood Pharmaceuticals, INC | $65.45 | 2022-2023 | Linzess |
| Ardelyx, INC. | $51.23 | 2025 | Ibsrela |
| Braintree Laboratories, INC. | $21.64 | 2023 | Sutab |
| Ferring Pharmaceuticals INC. | $18.91 | 2023 | Clenpiq |
| Celgene Corporation | $17.83 | 2021 | |
| Janssen Biotech, INC. | $17.74 | 2021 | |
| Merck Sharp & Dohme LLC | $17.42 | 2021 | |
| Redhill Biopharma INC. | $16.82 | 2021 | |
| Lilly USA, LLC | $16.75 | 2024 | Omvoh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Agnes Augustine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.